PharmacoEconomics - Open

SJR Rank #6,196H-index: 28SJR: 0.860Best quartile: Q2Open AccessAPC: US$4,090Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Country

Switzerland

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Health PolicyQ2
  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Health Systems, Economic Evaluations, Quality of LifeEconomic and Financial Impacts of CancerPharmaceutical Economics and PolicyEconomic and Environmental ValuationMultiple Sclerosis Research StudiesHealthcare Policy and ManagementMedication Adherence and ComplianceCancer Immunotherapy and BiomarkersHealthcare Systems and ReformsLung Cancer Treatments and Mutations

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

202220250255075100

Detailed Information

ISSN

2509-4262, 2509-4254

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.83

References per Document

48.48

Coverage

2017-2026

Scope

PharmacoEconomics - Open focuses on applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions. The journal includes, but is not limited to, the following research areas: Economic analysis of healthcare interventions; Health outcomes research; Cost-of-illness studies; Quality-of-life studies.

Metrics from SCImago Journal Rank 2025. View on SCImago